02354cam a22003013u 450000100060000000300070000600500170001300600020003000700050003200800410003704000110007804100170008905000070010610000700011324500680018326400510025130000470030233600260034933700260037533800360040150000310043750802030046852012550067153400450192665300210197185600430199299900170203547767UtSlPG20260610134110.0mcr n260607r2014||||utu|||||o|||||||||||||| d  aUtSlPG 7aen2iso639-1 4aRM1 aCouncil on Pharmacy and Chemistryq(American Medical Association)14aThe Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2 1aSalt Lake City, UT :bProject Gutenberg,c2014  a1 online resource :bmultiple file formats  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  aRelease date is 2014-12-24  aProduced by David Edwards, Thiers Halliwell and the Online
Distributed Proofreading Team at http://www.pgdp.net (This
file was produced from images generously made available
by The Internet Archive)  a"The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2" is a scientific publication likely written in the early 20th century. This volume serves as a continuation of the efforts of the American Medical Association and the Council on Pharmacy and Chemistry to address issues related to proprietary medicines, focusing on reports and insights that emerged from 1917 to 1922. The text critically analyzes the evolution of proprietary medicine practices, particularly the dubious therapeutic claims associated with various products, many of which were exposed as ineffectual or fraudulent.  At the start of this volume, the preface outlines the significant developments since the first volume, showcasing the Council's mission to protect both physicians and the public from misleading advertisements and claims surrounding proprietary medicines. It details the structure of the contents, including reports that assess medicinal products and the guidelines they must meet to be approved. This initial section emphasizes the importance of transparent information regarding composition and therapeutic claims, highlighting the Council's ongoing commitment to reform within the pharmaceutical industry. (This is an automatically generated summary.)  nOriginal publication data not identified  aPatent medicines40uhttps://www.gutenberg.org/ebooks/47767  c88606d88606